+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity

  • ID: 5232504
  • Report
  • December 2020
  • Region: Global
  • 168 pages
  • GMD Research

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • CMIC Co. Ltd
  • Covance Inc.
  • ICON Plc
  • IQVIA Holdings Inc.
  • Novotech Pty Ltd
  • PRA Health Sciences Inc.
The Global pharmaceutical CRO market will reach $104.4 billion by 2030, growing by 8.1% annually over 2020-2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 85 tables and 77 figures, this 168-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of the global market is forecast in an optimistic, balanced, and conservative view by taking into account the COVID-19 pandemic. The balanced (most likely) projection is used to quantify global pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.

Based on Service, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • CRO for Pre-clinical Development
  • CRO for Phase I Trials
  • CRO for Phase II Trials
  • CRO for Phase III Trials
  • CRO for Phase IV Trials
  • Laboratory Services
  • Consulting Services
  • Data Management Services
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Infectious Diseases
  • Oncology
  • Metabolic Disorders
  • Cardiovascular Disorders
  • Central Nervous System
  • Respiratory Disorders
  • Gastrointestinal Disorders
  • Other Therapeutic Applications
Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK Global Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CMIC Co. Ltd
  • Covance Inc.
  • ICON Plc
  • IQVIA Holdings Inc.
  • Novotech Pty Ltd
  • PRA Health Sciences Inc.
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Market by Service
3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 Segmentation of Global Market by Therapeutic Application
4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 Segmentation of Global Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 Segmentation of Global Market by Region
6.1 Geographic Market Overview 2019-2030
6.2 North America Market 2019-2030 by Country
6.2.1 Overview of North America Market
6.2.2 U.S.
6.2.3 Canada
6.2.4 Mexico
6.3 European Market 2019-2030 by Country
6.3.1 Overview of European Market
6.3.2 Germany
6.3.3 UK
6.3.4 France
6.3.5 Spain
6.3.6 Italy
6.3.7 Russia
6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2019-2030 by Country
6.4.1 Overview of Asia-Pacific Market
6.4.2 Japan
6.4.3 China
6.4.4 Australia
6.4.5 India
6.4.6 South Korea
6.4.7 Rest of APAC Region
6.5 South America Market 2019-2030 by Country
6.5.1 Argentina
6.5.2 Brazil
6.5.3 Chile
6.5.4 Rest of South America Market
6.6 MEA Market 2019-2030 by Country
6.6.1 UAE
6.6.2 Saudi Arabia
6.6.3 South Africa
6.6.4 Other National Markets

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK Global Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.
8 Investing in Global Market: Risk Assessment and Management
8.1 Risk Evaluation of Global Market
8.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Global Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. Main Product Trends and Market Opportunities in Global Pharmaceutical CRO Market
Table 6. Global Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 7. Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 8. Global Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 9. Global Pharmaceutical CRO Market by Region, 2019-2030, $ bn
Table 10. Leading National Pharmaceutical CRO Market, 2019 and 2030, $ bn
Table 11. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 12. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 13. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 14. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 15. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 16. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 17. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 18. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 19. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 20. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 21. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 22. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 23. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 24. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 25. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 26. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 27. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 28. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 29. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 30. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 31. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 32. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 33. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 34. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 35. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 36. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 37. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 38. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 39. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 40. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn
Table 41. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 42. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 43. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 44. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 45. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 46. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 47. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 48. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 49. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 50. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 51. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 52. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 53. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 54. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 55. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 56. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 57. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn
Table 58. South America Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 59. Argentina Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 60. Argentina Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 61. Argentina Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 62. Brazil Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 63. Brazil Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 64. Brazil Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 65. Chile Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 66. Chile Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 67. Chile Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 68. MEA Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 69. UAE Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 70. UAE Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 71. UAE Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 72. Saudi Arabia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 73. Saudi Arabia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 74. Saudi Arabia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 75. South Africa Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 76. South Africa Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 77. South Africa Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 78. Breakdown of Global Market by Key Vendor, 2019, %
Table 79. Charles River Laboratories: Company Snapshot
Table 80. Charles River Laboratories: Business Segmentation
Table 81. Charles River Laboratories: Product Portfolio
Table 82. Charles River Laboratories: Revenue, 2016-2018, $ bn
Table 83. Charles River Laboratories: Recent Developments
Table 84. Risk Evaluation for Investing in Global Market, 2019-2030
Table 85. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical CRO Market
Figure 8. Primary Restraints and Impact Factors of Global Pharmaceutical CRO Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Global Pharmaceutical CRO Market
Figure 11. Breakdown of Global Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 12. Global Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%)
Figure 13. Global Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 14. Global Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 15. Global Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 16. Global Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 17. Global Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 18. Global Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 19. Global Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 20. Global Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 21. Breakdown of Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 22. Global Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 23. Global Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 24. Global Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 25. Global Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 26. Global Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 27. Global Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 28. Global Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 29. Global Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 30. Global Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 31. Breakdown of Global Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 32. Global Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%)
Figure 33. Global Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 34. Global Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 35. Global Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 36. Global Market Snapshot by Region
Figure 37. Geographic Spread of Worldwide Pharmaceutical CRO Market, 2019-2030, % of Sales Revenue
Figure 38. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%)
Figure 39. North American Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 40. Breakdown of North America Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 41. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 42. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 43. Canada Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 44. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn
Figure 45. European Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 46. Breakdown of European Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 47. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 48. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn
Figure 49. Pharmaceutical CRO Market in UK, 2019-2030, $ bn
Figure 50. Pharmaceutical CRO Market in France, 2019-2030, $ bn
Figure 51. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn
Figure 52. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn
Figure 53. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn
Figure 54. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn
Figure 55. Asia-Pacific Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 56. Breakdown of APAC Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 57. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 58. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn
Figure 59. Pharmaceutical CRO Market in China, 2019-2030, $ bn
Figure 60. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn
Figure 61. Pharmaceutical CRO Market in India, 2019-2030, $ bn
Figure 62. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn
Figure 63. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn
Figure 64. South America Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 65. Breakdown of South America Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 66. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 67. Pharmaceutical CRO Market in Argentina, 2019-2030, $ bn
Figure 68. Pharmaceutical CRO Market in Brazil, 2019-2030, $ bn
Figure 69. Pharmaceutical CRO Market in Chile, 2019-2030, $ bn
Figure 70. Pharmaceutical CRO Market in Rest of South America, 2019-2030, $ bn
Figure 71. Pharmaceutical CRO Market in MEA, 2019-2030, $ bn
Figure 72. Breakdown of MEA Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 73. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 74. Pharmaceutical CRO Market in UAE, 2019-2030, $ bn
Figure 75. Pharmaceutical CRO Market in Saudi Arabia, 2019-2030, $ bn
Figure 76. Pharmaceutical CRO Market in South Africa, 2019-2030, $ bn
Figure 77. Growth Stage of Global Pharmaceutical CRO Industry over the Forecast Period
Note: Product cover images may vary from those shown
  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK Global Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll